Open in QuartrAvailable for iOS and Android

Cognetivity Neurosciences
Cognetivity Neurosciences Ltd. is a healthcare company, which engages in the development of an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia. The company was founded by Simone Ivonne Reinders and David Gill in 2017 and is headquartered in London, the United Kingdom.
Latest events on Quartr
Previous Events for Cognetivity Neurosciences
Ticker
CGN